DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
70.13
-0.22 (-0.31%)
Nov 4, 2024, 12:59 PM EST - Market open
DexCom Revenue
DexCom had revenue of $994.20M in the quarter ending September 30, 2024, with 1.97% growth. This brings the company's revenue in the last twelve months to $3.95B, up 16.19% year-over-year. In the year 2023, DexCom had annual revenue of $3.62B with 24.49% growth.
Revenue (ttm)
$3.95B
Revenue Growth
+16.19%
P/S Ratio
6.97
Revenue / Employee
$411,875
Employees
9,600
Market Cap
27.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.62B | 712.50M | 24.49% |
| Dec 31, 2022 | 2.91B | 461.30M | 18.84% |
| Dec 31, 2021 | 2.45B | 521.80M | 27.08% |
| Dec 31, 2020 | 1.93B | 450.70M | 30.54% |
| Dec 31, 2019 | 1.48B | 444.40M | 43.08% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Health | 224.45B |
| Centene | 146.20B |
| Humana | 115.01B |
| Koninklijke Philips | 20.12B |
| Biogen | 9.61B |
| Illumina | 4.43B |
| IDEXX Laboratories | 3.84B |
| Mettler-Toledo International | 3.75B |
DXCM News
- 9 days ago - These Analysts Revise Their Forecasts On DexCom Following Q3 Results - Benzinga
- 10 days ago - DexCom Beats Earnings Expectations. Why the Stock Is Trading Lower. - Barrons
- 10 days ago - Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 10 days ago - DexCom Growing Into Its Valuation, But Still No Bargain - Seeking Alpha
- 10 days ago - DexCom, Inc. (DXCM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Dexcom shares fall on slow revenue growth - CNBC
- 10 days ago - Dexcom beats estimates for third-quarter sales, reiterates annual forecast - Reuters
- 10 days ago - Dexcom Reports Third Quarter 2024 Financial Results - Business Wire